REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/24/2026
Back to search
Official data from USPTO
NEXT MOLECULAR ANALYTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEXT MOLECULAR ANALYTICS
ST13
US500000087048671Class
42, 44
Filing
87048671
Registration
5127583
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
01/25/2026
Trademark type
Word
Nice classes
42, 44
Filing date
05/24/2016
Registration date
01/24/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/29/2022
Last transaction
01/25/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
01/27/2016
First use in commerce
01/27/2016
Drawing code
4
Owner type
16
Owner location
Chester, VA
Examiner
CHUO, EMILY M
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
NEXT Bio-Research Services, LLC
Representatives
Teresa Stanek Rea CROWELL & MORING LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific laboratory services; chemical laboratory services; pharmacogenomics testing services for scientific research purposes; drug discovery services; scientific research and development; scientific laboratory services featuring laboratory support activities in support of human clinical trials; genetic testing for scientific research purposes; Clinical testing for othersconducting clinical trials for others in the field of genetics
Class 44
Clinical testing for othersconducting medical testing for diagnostic or treatment purposes; genetic testing for medical purposes; pharmacogenomics testing services for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
20 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/29/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/29/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/29/2022
E815
TEAS SECTION 8 & 15 RECEIVED
03/31/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2016
PUBO
PUBLISHED FOR OPPOSITION
11/08/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2016
ALIE
ASSIGNED TO LIE
09/26/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
09/12/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/12/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
09/12/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/12/2016
DOCK
ASSIGNED TO EXAMINER
09/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2016
NWAP
NEW APPLICATION ENTERED
05/27/2016
Continuous trademark protection
Get notified about every new filing that threatens NEXT MOLECULAR ANALYTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.